Loading…
Research and development reporting and stock performance: evidence from China
Purpose China adopted its new Accounting Standards for Business Enterprises No. 6 in 2007, which substantially converges with the International Financial Reporting Standards. It stipulates that firms operating in China shall capitalize development costs provided specific criteria have been met. This...
Saved in:
Published in: | International journal of accounting and information management 2023-03, Vol.31 (2), p.300-320 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c325t-9c7156ff067db2977bbaad6b66b1ab32f39df5bb72b59a9bb190bc8d227a0fd3 |
container_end_page | 320 |
container_issue | 2 |
container_start_page | 300 |
container_title | International journal of accounting and information management |
container_volume | 31 |
creator | Bai, Shuming Koong, Kai S. Wang, Yanni |
description | Purpose
China adopted its new Accounting Standards for Business Enterprises No. 6 in 2007, which substantially converges with the International Financial Reporting Standards. It stipulates that firms operating in China shall capitalize development costs provided specific criteria have been met. This paper aims to examine the effects of the new accounting policies of R&D on the value-relevance and stock performance of 36,299 Chinese firms-years from 2007 to 2020.
Design/methodology/approach
A comprehensive multi-stage analysis was conducted. Multiple linear regressions were performed on the pooled cross-sectional time-series total R&D, capitalized expenditures, expensed costs and other key financial factors to test for the effects of R&D on the stock prices, contemporaneous stock returns and subsequent stock returns for the full sample, capitalizer sample and expenser sample, respectively.
Findings
First, majority of Chinese firms (about 80% of those reported) elect to adopt expensing R&D approach, while about 20% deploys capitalization treatment. Second, key attributes such as size, profitability, leverage and R&D intensity are highly associated with capitalization propensity. Third, current capitalization affects the contemporaneous stock prices and stock returns (priced-in) with yearly volatility. Finally, intertemporal association exists between firms’ expensing costs and subsequent returns due to a delayed reaction.
Originality/value
As the world largest emerging economy, the results show that research and development information adds value, and capitalizers outperforms expensers in the area of stock performance. This strategy works irrespectively of economic development stage or capital market maturity. The findings call for more capitalization. |
doi_str_mv | 10.1108/IJAIM-08-2022-0171 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1108_IJAIM_08_2022_0171</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2792470046</sourcerecordid><originalsourceid>FETCH-LOGICAL-c325t-9c7156ff067db2977bbaad6b66b1ab32f39df5bb72b59a9bb190bc8d227a0fd3</originalsourceid><addsrcrecordid>eNptkE1LAzEQhoMoWKt_wFPA82qS3U023krxo9IiSO8hHxO7tbtZk23Bf--29aDgaR6Y952BB6FrSm4pJdXd7GUyW2SkyhhhLCNU0BM0olVeZIIX8vQXn6OLlNaEcFmQaoQWb5BAR7vCunXYwQ42oWug7XGELsS-bt8Pm9QH-4E7iD7ERrcW7jHsagcDYR9Dg6erutWX6MzrTYKrnzlGy8eH5fQ5m78-zaaTeWZzVvaZtIKW3HvChTNMCmGM1o4bzg3VJmc-l86XxghmSqmlMVQSYyvHmNDEu3yMbo5nuxg-t5B6tQ7b2A4fFROSFYKQgg8pdkzZGFKK4FUX60bHL0WJ2ltTB2tqgL01tbc2lOixBA1EvXH_d_6Yzr8BTgFvjQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2792470046</pqid></control><display><type>article</type><title>Research and development reporting and stock performance: evidence from China</title><source>Emerald:Jisc Collections:Emerald Subject Collections HE and FE 2024-2026:Emerald Premier (reading list)</source><creator>Bai, Shuming ; Koong, Kai S. ; Wang, Yanni</creator><creatorcontrib>Bai, Shuming ; Koong, Kai S. ; Wang, Yanni</creatorcontrib><description>Purpose
China adopted its new Accounting Standards for Business Enterprises No. 6 in 2007, which substantially converges with the International Financial Reporting Standards. It stipulates that firms operating in China shall capitalize development costs provided specific criteria have been met. This paper aims to examine the effects of the new accounting policies of R&D on the value-relevance and stock performance of 36,299 Chinese firms-years from 2007 to 2020.
Design/methodology/approach
A comprehensive multi-stage analysis was conducted. Multiple linear regressions were performed on the pooled cross-sectional time-series total R&D, capitalized expenditures, expensed costs and other key financial factors to test for the effects of R&D on the stock prices, contemporaneous stock returns and subsequent stock returns for the full sample, capitalizer sample and expenser sample, respectively.
Findings
First, majority of Chinese firms (about 80% of those reported) elect to adopt expensing R&D approach, while about 20% deploys capitalization treatment. Second, key attributes such as size, profitability, leverage and R&D intensity are highly associated with capitalization propensity. Third, current capitalization affects the contemporaneous stock prices and stock returns (priced-in) with yearly volatility. Finally, intertemporal association exists between firms’ expensing costs and subsequent returns due to a delayed reaction.
Originality/value
As the world largest emerging economy, the results show that research and development information adds value, and capitalizers outperforms expensers in the area of stock performance. This strategy works irrespectively of economic development stage or capital market maturity. The findings call for more capitalization.</description><identifier>ISSN: 1834-7649</identifier><identifier>EISSN: 1834-7649</identifier><identifier>EISSN: 1758-9037</identifier><identifier>DOI: 10.1108/IJAIM-08-2022-0171</identifier><language>eng</language><publisher>Bingley: Emerald Publishing Limited</publisher><subject>Accounting policies ; Balance sheets ; Capital markets ; Capital requirements ; Costs ; Emerging markets ; Intangible assets ; International Financial Reporting Standards ; Literature reviews ; Profitability ; Profits ; R&D ; Research & development ; Research & development expenditures ; Software</subject><ispartof>International journal of accounting and information management, 2023-03, Vol.31 (2), p.300-320</ispartof><rights>Emerald Group Publishing Limited</rights><rights>Emerald Group Publishing Limited.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c325t-9c7156ff067db2977bbaad6b66b1ab32f39df5bb72b59a9bb190bc8d227a0fd3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Bai, Shuming</creatorcontrib><creatorcontrib>Koong, Kai S.</creatorcontrib><creatorcontrib>Wang, Yanni</creatorcontrib><title>Research and development reporting and stock performance: evidence from China</title><title>International journal of accounting and information management</title><description>Purpose
China adopted its new Accounting Standards for Business Enterprises No. 6 in 2007, which substantially converges with the International Financial Reporting Standards. It stipulates that firms operating in China shall capitalize development costs provided specific criteria have been met. This paper aims to examine the effects of the new accounting policies of R&D on the value-relevance and stock performance of 36,299 Chinese firms-years from 2007 to 2020.
Design/methodology/approach
A comprehensive multi-stage analysis was conducted. Multiple linear regressions were performed on the pooled cross-sectional time-series total R&D, capitalized expenditures, expensed costs and other key financial factors to test for the effects of R&D on the stock prices, contemporaneous stock returns and subsequent stock returns for the full sample, capitalizer sample and expenser sample, respectively.
Findings
First, majority of Chinese firms (about 80% of those reported) elect to adopt expensing R&D approach, while about 20% deploys capitalization treatment. Second, key attributes such as size, profitability, leverage and R&D intensity are highly associated with capitalization propensity. Third, current capitalization affects the contemporaneous stock prices and stock returns (priced-in) with yearly volatility. Finally, intertemporal association exists between firms’ expensing costs and subsequent returns due to a delayed reaction.
Originality/value
As the world largest emerging economy, the results show that research and development information adds value, and capitalizers outperforms expensers in the area of stock performance. This strategy works irrespectively of economic development stage or capital market maturity. The findings call for more capitalization.</description><subject>Accounting policies</subject><subject>Balance sheets</subject><subject>Capital markets</subject><subject>Capital requirements</subject><subject>Costs</subject><subject>Emerging markets</subject><subject>Intangible assets</subject><subject>International Financial Reporting Standards</subject><subject>Literature reviews</subject><subject>Profitability</subject><subject>Profits</subject><subject>R&D</subject><subject>Research & development</subject><subject>Research & development expenditures</subject><subject>Software</subject><issn>1834-7649</issn><issn>1834-7649</issn><issn>1758-9037</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNptkE1LAzEQhoMoWKt_wFPA82qS3U023krxo9IiSO8hHxO7tbtZk23Bf--29aDgaR6Y952BB6FrSm4pJdXd7GUyW2SkyhhhLCNU0BM0olVeZIIX8vQXn6OLlNaEcFmQaoQWb5BAR7vCunXYwQ42oWug7XGELsS-bt8Pm9QH-4E7iD7ERrcW7jHsagcDYR9Dg6erutWX6MzrTYKrnzlGy8eH5fQ5m78-zaaTeWZzVvaZtIKW3HvChTNMCmGM1o4bzg3VJmc-l86XxghmSqmlMVQSYyvHmNDEu3yMbo5nuxg-t5B6tQ7b2A4fFROSFYKQgg8pdkzZGFKK4FUX60bHL0WJ2ltTB2tqgL01tbc2lOixBA1EvXH_d_6Yzr8BTgFvjQ</recordid><startdate>20230331</startdate><enddate>20230331</enddate><creator>Bai, Shuming</creator><creator>Koong, Kai S.</creator><creator>Wang, Yanni</creator><general>Emerald Publishing Limited</general><general>Emerald Group Publishing Limited</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7X1</scope><scope>7XB</scope><scope>AFKRA</scope><scope>ANIOZ</scope><scope>BENPR</scope><scope>BEZIV</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>K6~</scope><scope>L.-</scope><scope>PQBIZ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope></search><sort><creationdate>20230331</creationdate><title>Research and development reporting and stock performance: evidence from China</title><author>Bai, Shuming ; Koong, Kai S. ; Wang, Yanni</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c325t-9c7156ff067db2977bbaad6b66b1ab32f39df5bb72b59a9bb190bc8d227a0fd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Accounting policies</topic><topic>Balance sheets</topic><topic>Capital markets</topic><topic>Capital requirements</topic><topic>Costs</topic><topic>Emerging markets</topic><topic>Intangible assets</topic><topic>International Financial Reporting Standards</topic><topic>Literature reviews</topic><topic>Profitability</topic><topic>Profits</topic><topic>R&D</topic><topic>Research & development</topic><topic>Research & development expenditures</topic><topic>Software</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bai, Shuming</creatorcontrib><creatorcontrib>Koong, Kai S.</creatorcontrib><creatorcontrib>Wang, Yanni</creatorcontrib><collection>CrossRef</collection><collection>Accounting & Tax Database</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Central</collection><collection>Accounting, Tax & Banking Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Business Premium Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>ProQuest Business Collection</collection><collection>ABI/INFORM Professional Advanced</collection><collection>One Business (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><jtitle>International journal of accounting and information management</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bai, Shuming</au><au>Koong, Kai S.</au><au>Wang, Yanni</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Research and development reporting and stock performance: evidence from China</atitle><jtitle>International journal of accounting and information management</jtitle><date>2023-03-31</date><risdate>2023</risdate><volume>31</volume><issue>2</issue><spage>300</spage><epage>320</epage><pages>300-320</pages><issn>1834-7649</issn><eissn>1834-7649</eissn><eissn>1758-9037</eissn><abstract>Purpose
China adopted its new Accounting Standards for Business Enterprises No. 6 in 2007, which substantially converges with the International Financial Reporting Standards. It stipulates that firms operating in China shall capitalize development costs provided specific criteria have been met. This paper aims to examine the effects of the new accounting policies of R&D on the value-relevance and stock performance of 36,299 Chinese firms-years from 2007 to 2020.
Design/methodology/approach
A comprehensive multi-stage analysis was conducted. Multiple linear regressions were performed on the pooled cross-sectional time-series total R&D, capitalized expenditures, expensed costs and other key financial factors to test for the effects of R&D on the stock prices, contemporaneous stock returns and subsequent stock returns for the full sample, capitalizer sample and expenser sample, respectively.
Findings
First, majority of Chinese firms (about 80% of those reported) elect to adopt expensing R&D approach, while about 20% deploys capitalization treatment. Second, key attributes such as size, profitability, leverage and R&D intensity are highly associated with capitalization propensity. Third, current capitalization affects the contemporaneous stock prices and stock returns (priced-in) with yearly volatility. Finally, intertemporal association exists between firms’ expensing costs and subsequent returns due to a delayed reaction.
Originality/value
As the world largest emerging economy, the results show that research and development information adds value, and capitalizers outperforms expensers in the area of stock performance. This strategy works irrespectively of economic development stage or capital market maturity. The findings call for more capitalization.</abstract><cop>Bingley</cop><pub>Emerald Publishing Limited</pub><doi>10.1108/IJAIM-08-2022-0171</doi><tpages>21</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1834-7649 |
ispartof | International journal of accounting and information management, 2023-03, Vol.31 (2), p.300-320 |
issn | 1834-7649 1834-7649 1758-9037 |
language | eng |
recordid | cdi_crossref_primary_10_1108_IJAIM_08_2022_0171 |
source | Emerald:Jisc Collections:Emerald Subject Collections HE and FE 2024-2026:Emerald Premier (reading list) |
subjects | Accounting policies Balance sheets Capital markets Capital requirements Costs Emerging markets Intangible assets International Financial Reporting Standards Literature reviews Profitability Profits R&D Research & development Research & development expenditures Software |
title | Research and development reporting and stock performance: evidence from China |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T08%3A35%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Research%20and%20development%20reporting%20and%20stock%20performance:%20evidence%20from%20China&rft.jtitle=International%20journal%20of%20accounting%20and%20information%20management&rft.au=Bai,%20Shuming&rft.date=2023-03-31&rft.volume=31&rft.issue=2&rft.spage=300&rft.epage=320&rft.pages=300-320&rft.issn=1834-7649&rft.eissn=1834-7649&rft_id=info:doi/10.1108/IJAIM-08-2022-0171&rft_dat=%3Cproquest_cross%3E2792470046%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c325t-9c7156ff067db2977bbaad6b66b1ab32f39df5bb72b59a9bb190bc8d227a0fd3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2792470046&rft_id=info:pmid/&rfr_iscdi=true |